537 related articles for article (PubMed ID: 29852194)
1. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
3. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.
Herreros-Villanueva M; Duran-Sanchon S; Martín AC; Pérez-Palacios R; Vila-Navarro E; Marcuello M; Diaz-Centeno M; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; José Lozano J; García-Cougil M; Martínez-Arranz I; Castells A; Gironella M; Arroyo R
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00003. PubMed ID: 30702491
[TBL] [Abstract][Full Text] [Related]
4. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
5. Circulating biomarkers for early detection and clinical management of colorectal cancer.
Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
Slaby O
Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
[TBL] [Abstract][Full Text] [Related]
9. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.
Xiao Q; Lu W; Kong X; Shao YW; Hu Y; Wang A; Bao H; Cao R; Liu K; Wang X; Wu X; Zheng S; Yuan Y; Ding K
Cancer Lett; 2021 Feb; 499():201-208. PubMed ID: 33249197
[TBL] [Abstract][Full Text] [Related]
10. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
11. Liquid Biopsy for Colorectal Adenoma: Is the Exosomal miRNA Derived From Organoid a Potential Diagnostic Biomarker?
Handa T; Kuroha M; Nagai H; Shimoyama Y; Naito T; Moroi R; Kanazawa Y; Shiga H; Kakuta Y; Kinouchi Y; Masamune A
Clin Transl Gastroenterol; 2021 May; 12(5):e00356. PubMed ID: 33979310
[TBL] [Abstract][Full Text] [Related]
12. Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer.
Canale M; Marisi G; Passardi A; Scarpi E; Ulivi P
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30933052
[TBL] [Abstract][Full Text] [Related]
13. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
[TBL] [Abstract][Full Text] [Related]
14. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
[TBL] [Abstract][Full Text] [Related]
16. Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations.
ElSharawy A; Röder C; Becker T; Habermann JK; Schreiber S; Rosenstiel P; Kalthoff H
Oncotarget; 2016 Nov; 7(46):75353-75365. PubMed ID: 27683108
[TBL] [Abstract][Full Text] [Related]
17. Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers.
Gherman A; Balacescu L; Gheorghe-Cetean S; Vlad C; Balacescu O; Irimie A; Lisencu C
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197436
[TBL] [Abstract][Full Text] [Related]
18. Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives.
Galoș D; Gorzo A; Balacescu O; Sur D
Cells; 2022 Nov; 11(21):. PubMed ID: 36359889
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA-92a-3p in colorectal cancer: a review.
Yamada NO; Senda T
Med Mol Morphol; 2021 Sep; 54(3):193-202. PubMed ID: 33620640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
